A handheld device detects lung cancer biomarkers in breath and showed 90% accuracy in a pilot study; developers move toward ...
FDA flags Abbott glucose sensors after reports of incorrect readings linked to injuries and deaths, advising patients to stop using affected models.
By detecting subtle structural differences in volatile compounds, the sensors could power non-invasive breath tests for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback